Articles From: Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Cobalt International Energy, Inc. -- CIE to Galmed Pharmaceuticals to Present at the European Fatty Liver Conference


2015/1/12
NEW YORK, Jan.
Sign-up for Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Five Below, Inc. investment picks
2014/12/5
NEW YORK, Dec.
Sign-up for Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Sanofi -- SNY investment picks
2015/2/24
Program to include one trial to confirm the safety and therapeutic effect on fibrosis in NASH patients with cirrhosis, and a smaller trial to confirm the safety and therapeutic effect on NASH patients with advanced fibrosis Both studies to begin in the second quarter of 2015 Company to submit a Special Protocol Assessment to the FDA by the end of the month NORCROSS, Ga., Feb.
Sign-up for Galectin Therapeutics Announces Details of the Design of Its Phase 2 Program With GR-MD-02 investment picks
2014/12/1
NORCROSS, Ga., Dec.
Sign-up for Galectin Therapeutics to Present at 7th Annual LD Micro Main Event Conference investment picks
2015/2/9
Key PRESENT trial enrollment milestone achieved Over-enrollment planned with expected completion near the end of Q1 PORTLAND, Ore., Feb.
Sign-up for Galena Biopharma Enrolls 700th Patient in NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial investment picks
2015/1/20
PORTLAND, Ore., Jan.
Sign-up for Galena Biopharma Hires Joseph Lasaga as Vice President, Business Development and Alliance Management investment picks
2014/12/8
Phase 1 results demonstrate GALE-401 reduces platelet counts with tolerable safety profile Preliminary Phase 2 clinical trial data show promising platelet response with top-line data to be presented mid-year 2015 PORTLAND, Ore., Dec.
Sign-up for Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data at the 56th American Society of Hematology (ASH) Annual Meeting & Exposition investment picks
2015/1/8
PORTLAND, Ore., Jan.
Sign-up for Galena Biopharma Provides 2015 Outlook investment picks
2015/1/28
PORTLAND, Ore., Jan.
Sign-up for Galena Biopharma to Present at the 17th Annual BIO CEO & Investor Conference investment picks
2015/1/15
PORTLAND, Ore., Jan.
Sign-up for Galena Biopharma to Present at the Noble Financial Capital Markets 11th Annual Investor Conference investment picks
2015/2/19
PORTLAND, Ore., Feb.
Sign-up for Galena Biopharma to Report Fourth Quarter and Year End 2014 Financial Results on Thursday, March 5, 2015 investment picks
2014/12/3
BEDFORD, Texas , Dec.
Sign-up for Galenfeha Asset Tracking System Marks Another Field Success investment picks
2015/2/12
FT. WORTH, Texas , Feb.
Sign-up for Galenfeha Diversifies Product Line investment picks
2015/1/28
TEL-AVIV, Israel , Jan.
Sign-up for Galmed and Perrigo Execute Manufacturing Agreement for Large-Scale Aramchol API Production investment picks
2015/1/5
TEL AVIV, Israel , Jan.
Sign-up for Galmed Pharmaceuticals Announces the Appointment of Josh Blacher as Chief Financial Officer investment picks
2014/12/1
-- Results Confirm Favorable Safety Profile of Two High Doses of Aramchol --
Sign-up for Galmed Pharmaceuticals Completes Analysis of a Pharmacokinetic Study of Aramchol in Healthy Volunteers investment picks
2015/1/6
TEL AVIV, Israel , Jan.
Sign-up for Galmed Pharmaceuticals to Present at the Biotech Showcase™ investment picks
2015/2/25
TEL AVIV, Israel , Feb.
Sign-up for Galmed Pharmaceuticals to Present at the European Fatty Liver Conference investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Cobalt International Energy, Inc. -- CIE to Galmed Pharmaceuticals to Present at the European Fatty Liver Conference
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent